Advertisement

In Estimating Overdiagnosis, Details Matter

Published:October 27, 2015DOI:https://doi.org/10.1016/j.acra.2015.08.034
      I am deeply concerned about the recently published article by Dr. Archie Bleyer regarding screening mammography and the question of overdiagnosis (
      • Bleyer A.
      Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.
      ). Dr. Bleyer offers a review of the literature and update of his prior work, but he has not updated his puzzling approach and conclusions. My concerns are many, and I will address only some of them here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bleyer A.
        Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.
        Acad Radiol. 2015; 22: 949-960
        • Bleyer A.
        • Welch G.
        Effect of three decades of screening mammography on breast-cancer incidence.
        NEJM. 2012; 367: 1998-2005
        • Helvie M.A.
        • Chang J.T.
        • Hendrick E.
        • et al.
        Reduction in late-stage breast cancer incidence in the mammography era.
        Cancer. 2014; 120: 2649-2656
        • Cronin K.A.
        • Feuer E.J.
        • Clarke L.D.
        • et al.
        Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis.
        J Natl Cancer Inst Mongr. 2006; : 112-121
        • Tabár L.
        • Duffy S.W.
        • Yen M.-F.
        • et al.
        All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
        J Med Screen. 2002; 9: 159-162
        • Larsen S.U.
        • Rose C.
        [Spontaneous remission of breast cancer. A literature review].
        Ugeskr Laeger. 1999; 161: 4001-4004